GlassScriptPhysician profile
Nimra Nasir
NPI 1386468452
$357.09
in general payments reported to CMS, 2019-2025
9 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $106 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aveo Pharmaceuticals, INC. | $71.82 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $61.59 | 2025 | Keytruda |
| Pharmaessentia USA Corporation | $46.06 | 2025 | Besremi |
| Sobi, INC | $34.81 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $34.58 | 2024 | Calquence |
| Recordati_rare_diseases_inc. | $33.90 | 2025 | Enjaymo |
| Novartis Pharmaceuticals Corporation | $31.07 | 2025 | |
| Collegium Pharmaceutical, INC. | $22.46 | 2025 | Xtampza |
| Incyte Corporation | $20.80 | 2025 | Jakafi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nimra Nasir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.